How is a parathyroid adenoma diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Diagnosis of Parathyroid Adenoma

Parathyroid adenoma is diagnosed biochemically through elevated serum calcium with inappropriately elevated or non-suppressed parathyroid hormone (PTH) levels; imaging is used solely for preoperative localization, not for diagnosis. 1

Biochemical Diagnosis (Primary Hyperparathyroidism)

The diagnosis of primary hyperparathyroidism (PHPT) is established through laboratory testing:

  • Serum calcium: Elevated (hypercalcemia)
  • Parathyroid hormone (PTH): Inappropriately elevated or normal (should be suppressed in hypercalcemia)
  • Repeat measurements: Essential due to fluctuating calcium levels; correct for albumin or measure ionized calcium 2

Additional baseline laboratory evaluation 3, 2:

  • Serum phosphate (typically low)
  • 25-OH vitamin D3 levels
  • Glomerular filtration rate (eGFR) or creatinine clearance
  • 24-hour urinary calcium excretion

Imaging has no utility in confirming or excluding the diagnosis of PHPT 1. This is a critical pitfall—do not order imaging to "rule in" hyperparathyroidism.

When to Perform Imaging

Imaging should only be performed when surgery is planned 3, 2. The sole purpose is preoperative localization to guide minimally invasive parathyroidectomy (MIP) rather than bilateral neck exploration.

First-Line Imaging Strategy

The recommended first-line approach combines parathyroid ultrasound with functional imaging 3:

Option 1: Ultrasound + Sestamibi Scintigraphy

  • Parathyroid ultrasound (sensitivity 76-80%) 1
  • 99mTc-sestamibi scintigraphy with SPECT/CT, ideally dual-isotope 123I/99mTc-sestamibi subtraction (sensitivity 79-86%) 3, 1

Option 2: Ultrasound + 18F-Choline PET/CT

  • 18F-choline PET/CT shows excellent performance and is preferred when 3:
    • Age <40 years (higher risk of multigland disease)
    • Family history or genetic mutations (MEN1, CDC73)
    • Subtraction scintigraphy unavailable
    • Initial sestamibi scan is negative

Second-Line Imaging

If first-line imaging is negative or discordant 3:

  • Perform 18F-choline PET/CT if initial study was sestamibi
  • Consider 4D parathyroid CT (multiphase CT without and with IV contrast)
  • MRI neck (without and with contrast)
  • Fine needle aspiration with PTH measurement in washout fluid (after multidisciplinary discussion)

Special Considerations

Recurrent or persistent PHPT after surgery 1:

  • Preoperative imaging is essential to identify the lesion and postoperative anatomical changes
  • Multiple imaging modalities often needed for concordant localization
  • Consider selective venous sampling if noninvasive imaging is nonlocalizing

Secondary hyperparathyroidism 1:

  • Imaging goal is to identify all eutopic and ectopic glands (multigland disease expected)
  • Same imaging modalities but focus on comprehensive gland identification

Common Pitfalls

  • Do not use imaging to diagnose hyperparathyroidism—diagnosis is biochemical only
  • Do not order imaging if surgery is not planned—it provides no therapeutic benefit in medical management
  • Ultrasound sensitivity decreases with ectopic locations, posterior adenomas, small size, and concomitant thyroid disease 1
  • Sestamibi sensitivity decreases with multigland disease, thyroid nodules, small adenomas, and mild hypercalcemia 1

References

1
Guideline

acr appropriateness criteria® parathyroid adenoma.

Journal of the American College of Radiology, 2021

2
Research

[Primary hyperparathyreoidism - diagnostic procedures and management].

Deutsche medizinische Wochenschrift (1946), 2022

Related Questions

Does hyperparathyroidism-associated hypercalcemia cause a low serum creatinine level?
How should I evaluate and manage a patient with elevated ionized calcium, normal total calcium, and normal parathyroid hormone levels?
What is the appropriate work‑up and management for a patient with elevated ionized calcium and normal intact parathyroid hormone (PTH)?
What is the most likely diagnosis and recommended management for a patient with elevated intact parathyroid hormone (PTH), normal serum calcium, normal 25‑hydroxyvitamin D (25‑OH vitamin D), and low 24‑hour urinary calcium?
In a patient with positive CASPR antibodies, a 1 cm anterior mediastinal nodule on chest CT, and a history of dysautonomia, prior parathyroid surgery, hypoglycemia, and dumping syndrome, what imaging studies or specialist referrals should be pursued next?
What is the appropriate treatment for an acitrom‑induced INR of 6.5?
Do mural nodules in a pancreatic mucinous cystic neoplasm indicate malignancy?
In an adult with type 2 diabetes, HbA1c 7.2 % and random glucose 160 mg/dL, can a triple oral regimen of dapagliflozin 10 mg daily, sitagliptin 100 mg daily, and metformin 1000 mg daily be prescribed?
What triple therapy regimen is recommended for a patient with type 2 diabetes who is currently on dapagliflozin 10 mg?
What is the FIGO stage of ovarian carcinoma when the right and left lymph nodes are reactive (non‑metastatic)?
Are home‑based self‑administered NIPPY (positive airway pressure) devices appropriate for chronic management of this patient's sleep apnea?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.